Wegovy-maker Novo Nordisk presented new data on Wednesday showing its experimental weight-loss pill improved blood sugar ...
The 72-week multinational phase 3 ATTAIN-2 trial randomized 1613 participants with obesity or overweight (BMI ≥ 27.0) and T2D ...
At 12 weeks, a combination pill containing candesartan cilexetil, amlodipine, and chlorthalidone improved BP in patients with hypertension.
Senators cite study showing 22 times higher serious side effects from chemical abortion drugs than FDA labels indicate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback